Tag: cell expansion market forecast

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cell Expansion Market Forecast Highlighting Growth From $37.54 Billion To $69.41 Billion

The cell expansion market has experienced a significant surge, projected to expand from its 2025 valuation of $32.31 billion to $37.54 billion by 2026, reflecting a compound annual growth rate of 16.2%. This expansion during the earlier period was fueled by several key factors including the increased capacity in biopharmaceutical manufacturing, the growing reliance on mammalian cell cultures, the integration of cell expansion techniques into vaccine development, the proliferation of research-focused cell cultivation, and the increasing availability of disposable culture systems.

The cell expansion market is poised for substantial expansion in the coming years, projected to reach $69.42 billion by 2030, demonstrating a compound annual growth rate of 16.6%. This upward trajectory during the forecast period is fueled by several key factors: the escalating demand for cell and gene therapies, augmented investments directed towards large-scale biopharmaceutical production, the broadening of regenerative medicine research and development, a heightened emphasis on developing cost-effective scaling solutions, and the increasing integration of closed-system expansion technologies. Furthermore, several significant trends are shaping this market, including a greater embrace of single-use cell expansion systems, a growing need for adaptable and scalable cell culture platforms, the expanding application of serum-free expansion media, the proliferation of automated bioreactor systems, and a stronger commitment to standardizing manufacturing processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8264&type=smp

Cell Expansion Market Demand Drivers: What Is Fueling Industry Growth?

Enhanced government investment in research and development initiatives is anticipated to be a significant catalyst for the expansion of the cell expansion market. This government funding, defined as financial resources allocated by a governing body for specific objectives, is instrumental in nurturing novel ideas, propelling progress in cellular therapies, and expediting the evolution of regenerative medicine. As an illustration, the National Cancer Institute, a governmental entity in the United States, was allocated a budget of $7.3 billion for fiscal year 2023 by the U.S. Congress in September 2023, marking an augmentation of $408 million compared to the preceding year. Consequently, heightened government investment in R&D is acting as a key driver for the growth trajectory of the cell expansion market.

Cell Expansion Market Segment Outlook: Which Categories Are Expanding The Fastest?

The cell expansion market covered in this report is segmented –

1) By Cell Type: Mammalian, Microbial, Other Cell Types

2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments

3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications

4) By End-User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users

Subsegments:

1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells

2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells

3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells

Cell Expansion Market Innovation Trends: Which Developments Are Transforming The Industry?

Leading players within the cell expansion sector are focusing on enhancing bioprocessing methods, including sophisticated automated 3D bioreactor setups, to boost the effectiveness and expandability of cellular manufacturing for medical treatments; PluriCDMO, for example, specializes in high-volume, automated cell therapy production leveraging its proprietary 3D bioreactor technology, guaranteeing reliable, premium output from initial research phases right up to clinical evaluation, and as a demonstration of this commitment, Pluristem Therapeutics Inc., an Israeli biotech firm, introduced PluriCDMO in January 2024, a dedicated operational unit aimed at delivering cell therapy manufacturing services as a contract development and manufacturing organization, featuring a 47,000-square-foot facility compliant with good manufacturing practice (GMP) standards for cell therapy production, thereby enabling Pluri to deliver comprehensive support from preclinical research and development through to late-stage clinical trials and eventual market release.

Cell Expansion Market Key Companies And Competitive Benchmarking

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd.

Access The Complete Cell Expansion Market Report:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Cell Expansion Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the cell expansion market share in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cell Expansion Market Forecast Highlighting Growth From $37.54 Billion To $69.41 Billion

The cell expansion market has experienced a significant surge, projected to expand from its 2025 valuation of $32.31 billion to $37.54 billion by 2026, reflecting a compound annual growth rate of 16.2%. This expansion during the earlier period was fueled by several key factors including the increased capacity in biopharmaceutical manufacturing, the growing reliance on mammalian cell cultures, the integration of cell expansion techniques into vaccine development, the proliferation of research-focused cell cultivation, and the increasing availability of disposable culture systems.

The cell expansion market is poised for substantial expansion in the coming years, projected to reach $69.42 billion by 2030, demonstrating a compound annual growth rate of 16.6%. This upward trajectory during the forecast period is fueled by several key factors: the escalating demand for cell and gene therapies, augmented investments directed towards large-scale biopharmaceutical production, the broadening of regenerative medicine research and development, a heightened emphasis on developing cost-effective scaling solutions, and the increasing integration of closed-system expansion technologies. Furthermore, several significant trends are shaping this market, including a greater embrace of single-use cell expansion systems, a growing need for adaptable and scalable cell culture platforms, the expanding application of serum-free expansion media, the proliferation of automated bioreactor systems, and a stronger commitment to standardizing manufacturing processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8264&type=smp

Cell Expansion Market Demand Drivers: What Is Fueling Industry Growth?

Enhanced government investment in research and development initiatives is anticipated to be a significant catalyst for the expansion of the cell expansion market. This government funding, defined as financial resources allocated by a governing body for specific objectives, is instrumental in nurturing novel ideas, propelling progress in cellular therapies, and expediting the evolution of regenerative medicine. As an illustration, the National Cancer Institute, a governmental entity in the United States, was allocated a budget of $7.3 billion for fiscal year 2023 by the U.S. Congress in September 2023, marking an augmentation of $408 million compared to the preceding year. Consequently, heightened government investment in R&D is acting as a key driver for the growth trajectory of the cell expansion market.

Cell Expansion Market Segment Outlook: Which Categories Are Expanding The Fastest?

The cell expansion market covered in this report is segmented –

1) By Cell Type: Mammalian, Microbial, Other Cell Types

2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments

3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications

4) By End-User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users

Subsegments:

1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells

2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells

3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells

Cell Expansion Market Innovation Trends: Which Developments Are Transforming The Industry?

Leading players within the cell expansion sector are focusing on enhancing bioprocessing methods, including sophisticated automated 3D bioreactor setups, to boost the effectiveness and expandability of cellular manufacturing for medical treatments; PluriCDMO, for example, specializes in high-volume, automated cell therapy production leveraging its proprietary 3D bioreactor technology, guaranteeing reliable, premium output from initial research phases right up to clinical evaluation, and as a demonstration of this commitment, Pluristem Therapeutics Inc., an Israeli biotech firm, introduced PluriCDMO in January 2024, a dedicated operational unit aimed at delivering cell therapy manufacturing services as a contract development and manufacturing organization, featuring a 47,000-square-foot facility compliant with good manufacturing practice (GMP) standards for cell therapy production, thereby enabling Pluri to deliver comprehensive support from preclinical research and development through to late-stage clinical trials and eventual market release.

Cell Expansion Market Key Companies And Competitive Benchmarking

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd.

Access The Complete Cell Expansion Market Report:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Cell Expansion Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the cell expansion market share in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cell Expansion Market Forecast Highlighting Growth From $37.54 Billion To $69.41 Billion

The cell expansion market has experienced a significant surge, projected to expand from its 2025 valuation of $32.31 billion to $37.54 billion by 2026, reflecting a compound annual growth rate of 16.2%. This expansion during the earlier period was fueled by several key factors including the increased capacity in biopharmaceutical manufacturing, the growing reliance on mammalian cell cultures, the integration of cell expansion techniques into vaccine development, the proliferation of research-focused cell cultivation, and the increasing availability of disposable culture systems.

The cell expansion market is poised for substantial expansion in the coming years, projected to reach $69.42 billion by 2030, demonstrating a compound annual growth rate of 16.6%. This upward trajectory during the forecast period is fueled by several key factors: the escalating demand for cell and gene therapies, augmented investments directed towards large-scale biopharmaceutical production, the broadening of regenerative medicine research and development, a heightened emphasis on developing cost-effective scaling solutions, and the increasing integration of closed-system expansion technologies. Furthermore, several significant trends are shaping this market, including a greater embrace of single-use cell expansion systems, a growing need for adaptable and scalable cell culture platforms, the expanding application of serum-free expansion media, the proliferation of automated bioreactor systems, and a stronger commitment to standardizing manufacturing processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8264&type=smp

Cell Expansion Market Demand Drivers: What Is Fueling Industry Growth?

Enhanced government investment in research and development initiatives is anticipated to be a significant catalyst for the expansion of the cell expansion market. This government funding, defined as financial resources allocated by a governing body for specific objectives, is instrumental in nurturing novel ideas, propelling progress in cellular therapies, and expediting the evolution of regenerative medicine. As an illustration, the National Cancer Institute, a governmental entity in the United States, was allocated a budget of $7.3 billion for fiscal year 2023 by the U.S. Congress in September 2023, marking an augmentation of $408 million compared to the preceding year. Consequently, heightened government investment in R&D is acting as a key driver for the growth trajectory of the cell expansion market.

Cell Expansion Market Segment Outlook: Which Categories Are Expanding The Fastest?

The cell expansion market covered in this report is segmented –

1) By Cell Type: Mammalian, Microbial, Other Cell Types

2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments

3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications

4) By End-User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users

Subsegments:

1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells

2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells

3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells

Cell Expansion Market Innovation Trends: Which Developments Are Transforming The Industry?

Leading players within the cell expansion sector are focusing on enhancing bioprocessing methods, including sophisticated automated 3D bioreactor setups, to boost the effectiveness and expandability of cellular manufacturing for medical treatments; PluriCDMO, for example, specializes in high-volume, automated cell therapy production leveraging its proprietary 3D bioreactor technology, guaranteeing reliable, premium output from initial research phases right up to clinical evaluation, and as a demonstration of this commitment, Pluristem Therapeutics Inc., an Israeli biotech firm, introduced PluriCDMO in January 2024, a dedicated operational unit aimed at delivering cell therapy manufacturing services as a contract development and manufacturing organization, featuring a 47,000-square-foot facility compliant with good manufacturing practice (GMP) standards for cell therapy production, thereby enabling Pluri to deliver comprehensive support from preclinical research and development through to late-stage clinical trials and eventual market release.

Cell Expansion Market Key Companies And Competitive Benchmarking

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd.

Access The Complete Cell Expansion Market Report:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Cell Expansion Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the cell expansion market share in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Cell Expansion Market Over The 2026–2030 Period?

The cell expansion market size has observed rapid growth over recent years. It is projected to expand from $32.31 billion in 2025 to $37.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.2%. The historical growth can be attributed to factors like the expansion of biopharmaceutical manufacturing, the increasing utilization of mammalian cell cultures, the integration of cell expansion into vaccine production, the development of research-scale cell cultivation, and the availability of disposable culture systems.

The cell expansion market is projected to expand significantly, reaching $69.42 billion by 2030, driven by a compound annual growth rate (CAGR) of 16.6%. This anticipated growth is primarily fueled by factors such as the rising demand for cell and gene therapies, increased investments in large-scale biologics manufacturing, the broadening of regenerative medicine pipelines, an intensified focus on achieving cost-efficient scale-up, and the wider uptake of closed-system expansion technologies. Key developments expected during this forecast period involve the greater adoption of single-use cell expansion systems, an increasing need for scalable cell culture platforms, the expanding utilization of serum-free expansion media, the growth of automated bioreactor systems, and a heightened emphasis on standardizing processes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Which Factors Are Influencing The Growth Of The Cell Expansion Market?

The cell expansion market is projected to grow as government funding for research and development increases. This financial backing from governments, provided for particular purposes, is vital for encouraging innovation, advancing cell-based therapies, and accelerating progress in regenerative medicine. For example, in September 2023, the National Cancer Institute, a US-based government agency, secured a budget of $7.3 billion for fiscal year 2023 from the United States Congress, marking a $408 million increase over 2022. Consequently, the rise in government funding for research and development is a significant factor driving the expansion of the cell expansion market.

How Is The Cell Expansion Market Segmented Across Different Segment Categories?

The cell expansion market covered in this report is segmented –

1) By Cell Type: Mammalian, Microbial, Other Cell Types

2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments

3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications

4) By End-User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users

Subsegments:

1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells

2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells

3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells

Which Trends Are Influencing Demand In The Cell Expansion Market?

Leading companies in the cell expansion market are emphasizing advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to improve the efficiency and scalability of cell production for therapeutic applications. PluriCDMO offers large-scale, automated cell therapy manufacturing utilizing a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development through clinical trials. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotechnology company, introduced a new business division called PluriCDMO, which will provide cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). This new division encompasses a 47,000-ft2 good manufacturing practice (GMP) cell therapy production facility. Through this new segment, Pluri intends to offer services ranging from early preclinical development to late-stage clinical trials and commercialization.

Which Organizations Play A Role In The Cell Expansion Market Landscape?

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd.

Get The Full Cell Expansion Market Report:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Which Region Accounts For The Largest Portion Of The Cell Expansion Market?

North America was the largest region in the cell expansion market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Expansion Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Browse Through More Reports Similar to the Global Cell Expansion Market 2026, By The Business Research Company

Cell Separation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-separation-global-market-report

Cell Counting Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report

Cell Cultures Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Cell Expansion Market Expected To Change Between 2026 And 2030?

The cell expansion market has experienced substantial growth recently. Projections indicate its expansion from $32.31 billion in 2025 to reach $37.54 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 16.2%. Historically, this growth can be attributed to factors such as the expansion of biopharmaceutical manufacturing, increased utilization of mammalian cell cultures, the integration of cell expansion into vaccine production, the rise in research-scale cell cultivation, and the accessibility of disposable culture systems.

The cell expansion market is projected to experience substantial growth over the coming years. By 2030, its value is anticipated to reach $69.42 billion, exhibiting a compound annual growth rate (CAGR) of 16.6%. This projected expansion is primarily driven by factors such as the escalating need for cell and gene therapies, increased funding in extensive biologics manufacturing, the broadening scope of regenerative medicine research, a heightened emphasis on economical scaling solutions, and the wider integration of closed-system expansion methods. Key developments expected during this period include the rising acceptance of disposable cell expansion setups, a growing need for adaptable cell culture platforms, the increased application of serum-free expansion media, the deployment of automated bioreactor systems, and a strengthened commitment to standardizing processes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8264&type=smp

Which Major Factors Are Driving The Expansion Of The Cell Expansion Market?

Increased governmental financial backing for research and development is projected to boost the cell expansion market in the coming years. Government funding, which refers to monetary support provided by a government for a particular aim, is essential for fostering innovation, advancing cell-based therapies, and accelerating progress in regenerative medicine. As an illustration, in September 2023, the National Cancer Institute, a US-based government agency, received a budget of $7.3 billion from the United States Congress for fiscal year 2023, marking a $408 million increase over 2022. Therefore, the growing government funding for research and development is a key driver for the cell expansion market’s growth.

How Is The Cell Expansion Market Structured Across Different Segments?

The cell expansion market covered in this report is segmented –

1) By Cell Type: Mammalian, Microbial, Other Cell Types

2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments

3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications

4) By End-User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users

Subsegments:

1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells

2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells

3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells

What Industry Trends Are Redefining The Cell Expansion Market?

Leading companies in the cell expansion market are prioritizing advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to enhance the efficiency and scalability of cell production for therapeutic applications. PluriCDMO provides large-scale, automated cell therapy manufacturing using a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development through clinical trials. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotechnology company, launched a new business division named PluriCDMO to offer cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). This new division includes a 47,000-ft2 good manufacturing practice (GMP) cell therapy production facility. Through this new division, Pluri will offer services relating to early preclinical development through late-stage clinical trials and commercialization.

Which Major Players Dominate The Cell Expansion Market?

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd.

Read the full cell expansion market report here:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Which Region Currently Holds The Largest Share Of The Cell Expansion Market?

North America was the largest region in the cell expansion market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Expansion Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8264&type=smp

Browse Through More Reports Similar to the Global Cell Expansion Market 2026, By The Business Research Company

Cell Culture Consumables And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Stem Cell Cord Blood Banking Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Induced Pluripotent Stem Cell Global Market Report

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Cell Expansion Market Expected To Change Between 2026 And 2030?

The cell expansion market has experienced substantial growth recently. Projections indicate its expansion from $32.31 billion in 2025 to reach $37.54 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 16.2%. Historically, this growth can be attributed to factors such as the expansion of biopharmaceutical manufacturing, increased utilization of mammalian cell cultures, the integration of cell expansion into vaccine production, the rise in research-scale cell cultivation, and the accessibility of disposable culture systems.

The cell expansion market is projected to experience substantial growth over the coming years. By 2030, its value is anticipated to reach $69.42 billion, exhibiting a compound annual growth rate (CAGR) of 16.6%. This projected expansion is primarily driven by factors such as the escalating need for cell and gene therapies, increased funding in extensive biologics manufacturing, the broadening scope of regenerative medicine research, a heightened emphasis on economical scaling solutions, and the wider integration of closed-system expansion methods. Key developments expected during this period include the rising acceptance of disposable cell expansion setups, a growing need for adaptable cell culture platforms, the increased application of serum-free expansion media, the deployment of automated bioreactor systems, and a strengthened commitment to standardizing processes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8264&type=smp

Which Major Factors Are Driving The Expansion Of The Cell Expansion Market?

Increased governmental financial backing for research and development is projected to boost the cell expansion market in the coming years. Government funding, which refers to monetary support provided by a government for a particular aim, is essential for fostering innovation, advancing cell-based therapies, and accelerating progress in regenerative medicine. As an illustration, in September 2023, the National Cancer Institute, a US-based government agency, received a budget of $7.3 billion from the United States Congress for fiscal year 2023, marking a $408 million increase over 2022. Therefore, the growing government funding for research and development is a key driver for the cell expansion market’s growth.

How Is The Cell Expansion Market Structured Across Different Segments?

The cell expansion market covered in this report is segmented –

1) By Cell Type: Mammalian, Microbial, Other Cell Types

2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments

3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications

4) By End-User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users

Subsegments:

1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells

2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells

3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells

What Industry Trends Are Redefining The Cell Expansion Market?

Leading companies in the cell expansion market are prioritizing advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to enhance the efficiency and scalability of cell production for therapeutic applications. PluriCDMO provides large-scale, automated cell therapy manufacturing using a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development through clinical trials. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotechnology company, launched a new business division named PluriCDMO to offer cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). This new division includes a 47,000-ft2 good manufacturing practice (GMP) cell therapy production facility. Through this new division, Pluri will offer services relating to early preclinical development through late-stage clinical trials and commercialization.

Which Major Players Dominate The Cell Expansion Market?

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd.

Read the full cell expansion market report here:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Which Region Currently Holds The Largest Share Of The Cell Expansion Market?

North America was the largest region in the cell expansion market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Expansion Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8264&type=smp

Browse Through More Reports Similar to the Global Cell Expansion Market 2026, By The Business Research Company

Cell Culture Consumables And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Stem Cell Cord Blood Banking Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Induced Pluripotent Stem Cell Global Market Report

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Cell Expansion Market Expected To Change Between 2026 And 2030?

The cell expansion market has experienced substantial growth recently. Projections indicate its expansion from $32.31 billion in 2025 to reach $37.54 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 16.2%. Historically, this growth can be attributed to factors such as the expansion of biopharmaceutical manufacturing, increased utilization of mammalian cell cultures, the integration of cell expansion into vaccine production, the rise in research-scale cell cultivation, and the accessibility of disposable culture systems.

The cell expansion market is projected to experience substantial growth over the coming years. By 2030, its value is anticipated to reach $69.42 billion, exhibiting a compound annual growth rate (CAGR) of 16.6%. This projected expansion is primarily driven by factors such as the escalating need for cell and gene therapies, increased funding in extensive biologics manufacturing, the broadening scope of regenerative medicine research, a heightened emphasis on economical scaling solutions, and the wider integration of closed-system expansion methods. Key developments expected during this period include the rising acceptance of disposable cell expansion setups, a growing need for adaptable cell culture platforms, the increased application of serum-free expansion media, the deployment of automated bioreactor systems, and a strengthened commitment to standardizing processes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8264&type=smp

Which Major Factors Are Driving The Expansion Of The Cell Expansion Market?

Increased governmental financial backing for research and development is projected to boost the cell expansion market in the coming years. Government funding, which refers to monetary support provided by a government for a particular aim, is essential for fostering innovation, advancing cell-based therapies, and accelerating progress in regenerative medicine. As an illustration, in September 2023, the National Cancer Institute, a US-based government agency, received a budget of $7.3 billion from the United States Congress for fiscal year 2023, marking a $408 million increase over 2022. Therefore, the growing government funding for research and development is a key driver for the cell expansion market’s growth.

How Is The Cell Expansion Market Structured Across Different Segments?

The cell expansion market covered in this report is segmented –

1) By Cell Type: Mammalian, Microbial, Other Cell Types

2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments

3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications

4) By End-User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users

Subsegments:

1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells

2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells

3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells

What Industry Trends Are Redefining The Cell Expansion Market?

Leading companies in the cell expansion market are prioritizing advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to enhance the efficiency and scalability of cell production for therapeutic applications. PluriCDMO provides large-scale, automated cell therapy manufacturing using a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development through clinical trials. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotechnology company, launched a new business division named PluriCDMO to offer cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). This new division includes a 47,000-ft2 good manufacturing practice (GMP) cell therapy production facility. Through this new division, Pluri will offer services relating to early preclinical development through late-stage clinical trials and commercialization.

Which Major Players Dominate The Cell Expansion Market?

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd.

Read the full cell expansion market report here:

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Which Region Currently Holds The Largest Share Of The Cell Expansion Market?

North America was the largest region in the cell expansion market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Expansion Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8264&type=smp

Browse Through More Reports Similar to the Global Cell Expansion Market 2026, By The Business Research Company

Cell Culture Consumables And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Stem Cell Cord Blood Banking Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Induced Pluripotent Stem Cell Global Market Report

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model